Biotech

Startups News

Biotech Startups Essentials publishes only the best Biotech news and links, carefully hand-picked and curated by top biotech experts.

Top news of the week: 22.12.2021.

Biotechnology
Medicine
Drug
Pharmaceutical drug
Classification of Pharmaco-Therapeutic Referrals
Fingerprick

Startups

@ForbesTech shared
On Dec 16, 2021
Maker Of Home Blood-Draw Kits, Tasso, Raises $100 Million Led By RA Capital https://t.co/36HDAO4M5K https://t.co/XcHaZn2Nlk
Open
Tasso, Maker Of Home Blood-Draw Kits, Raises $100 Million Led By RA Capital

Tasso, Maker Of Home Blood-Draw Kits, Raises $100 Million Led By RA Capital

Seattle-based Tasso, founded by two biomedical engineering Ph.D.s, raises $100 million to ramp up production of its home blood-draw kits.

@ForbesTech shared
On Dec 16, 2021
Amazon And UPS Are Betting This Electric Aircraft Startup Will Change Shipping https://t.co/0WlU2W2Jw0 https://t.co/B0dEjznYOH
Open
Amazon And UPS Are Betting This Electric Aircraft Startup Will Change Shipping

Amazon And UPS Are Betting This Electric Aircraft Startup Will Change Shipping

A former pro hockey player, Harvard grad Kyle Clark’s startup Beta Technologies may be on the verge of bringing workhorse battery-powered cargo planes to America’s skies that take off and ...

@Forbes shared
On Dec 18, 2021
Alarming Arctic Study, Accelerating The EV Transition, And The Top 10 Sustainability Stories Of 2021: https://t.co/2yDiZLq8mH
Open
Alarming Arctic Study, Accelerating The EV Transition, And The Top 10 Sustainability Stories Of 2021

Alarming Arctic Study, Accelerating The EV Transition, And The Top 10 Sustainability Stories Of 2021

This week’s Current Climate, which every Saturday brings you a balanced view of sustainability news.

@ldtimmerman shared
On Dec 21, 2021
Thinking about health data and how to make better use of it. Listen to the latest Long Run podcast with @vintweeta @a16z https://t.co/IYhhv1nX4v
Open
Physician-Scientist-Biotech VC: Vineeta Agarwala on The Long Run

Physician-Scientist-Biotech VC: Vineeta Agarwala on The Long Run

Today’s guest on The Long Run is Vineeta Agarwala. Vineeta is a general partner with Andreesen Horowitz’s bio fund. Vineeta has spent a lot of time on the front lines of an explosion in ...

@BusinessInsider shared
On Dec 20, 2021
34 healthcare and biotech startups that are set to take off in 2022, according to top investors https://t.co/xXDwf7CoJF
Open
34 healthcare and biotech startups that are set to take off in 2022, according to top investors

34 healthcare and biotech startups that are set to take off in 2022, according to top investors

We asked investors for the startups that are poised for success, from new ways of providing care to cutting-edge approaches to drug development.

@BentheFidler shared
On Dec 21, 2021
Sanofi to buy cancer immunotherapy #biotech for $1B https://t.co/5VFzDp40iR by @NedPagliarulo $SNY
Open
Sanofi to buy cancer immunotherapy biotech for $1B

Sanofi to buy cancer immunotherapy biotech for $1B

The French drugmaker is interested in Amunix Pharmaceuticals' technology, which could allow for more precise delivery of biologic drugs into cancerous tissue.

@BentheFidler shared
On Dec 16, 2021
Flush with cash, large drugmakers turn to share buybacks, deals https://t.co/ju0sKmOeIJ by @NedPagliarulo $NVS $BMY
Open
Flush with cash, large drugmakers turn to share buybacks, deals

Flush with cash, large drugmakers turn to share buybacks, deals

Novartis is using funds gained from the recent sale of its stake in Roche to buy back $15 billion worth of its own shares, while Pfizer is signaling more dealmaking could follow its buyout ...

@BentheFidler shared
On Dec 17, 2021
Spark expands in Philadelphia, with new facility meant to be Roche's gene therapy hub https://t.co/ZnRXKW8XBL by @NedPagliarulo $RHHBY
Open
Spark expands in Philadelphia, with new facility meant to be Roche's gene therapy hub

Spark expands in Philadelphia, with new facility meant to be Roche's gene therapy hub

The Luxturna developer, now owned by Roche, will invest $575 million to build a huge research and development center on Drexel University's campus.